RxDoctor Payments Data

Gregory Lesnik, MD

Otolaryngology · Norwich, CTNPI 1710157805

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,000 of the $3,413 with a category attached, or 87.9%. KARL Storz Endoscopy-america accounts for 87.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $3,000 and has fallen 93.2% since, to $205 in 2025.

$3,413in general payments, 2019–2025

Across 17 payments — averaging $200.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KARL Storz Endoscopy-america$3K
  • Regeneron Healthcare Solutions, Inc.$187
  • Stryker$80
  • GSK$75
  • Sanofi$43
  • Merck$29

What the payments were for

  • Consulting fees$3,00088%
  • Food & beverage$41312%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,413 in reported general payments places this provider in the 70th percentile of 119 otolaryngology providers in Connecticut.

See all otolaryngology providers in Connecticut

Medicare billing

Part B allowed, 2024
$149,036
Medicare patients
548
Services billed
1,327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin79$3,237
Ipratropium Bromide77$2,300
Fluocinolone Acetonide Oil46$1,644
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort26$1,481
Fluticasone Propionate43$744
Methylprednisolone80$566
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav41$394
Mometasone Furoate14$216
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid12$176
Mupirocin29$175
Azithromycin53$160
Meclizine Hcl14$90
Omeprazole13$80

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Norwich

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →